Andrew Bernier

Andrew Bernier is an experienced marketing professional currently serving as the Associate Director of Marketing at Intra-Cellular Therapies, where responsibilities include the launch of CAPLYTA for Bipolar I and II Depression. Previously, Andrew held the position of Senior Product Manager for the digital launch of CAPLYTA in the treatment of schizophrenia. Prior to joining Intra-Cellular Therapies, Andrew worked as an Advertising Account Manager at various advertising agencies from January 2012 to February 2020, gaining extensive HCP and DTC marketing experience within the pharmaceutical sector, contributing to significant product launches for notable companies including Pfizer, Takeda, Purdue Pharma, Raptor Pharmaceuticals, and Hansa Biopharma. Andrew holds a Bachelor of Science degree from the University of Michigan.